Long term treatment of advanced endometrial cancer with lenvatinib and pembrolizumab
Objective: To describe a case of sustained disease control for over five years in a patient with recurrent, advanced endometrial cancer treated with lenvatinib and pembrolizumab, despite significant treatment-related toxicities. Methods: We present a 49-year-old patient with grade 3, stage IVB endom...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Gynecologic Oncology Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578925000426 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|